159
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Developing a Mobile Health Application to Communicate Adverse Drug Reactions – Preconditions, Assessment of Possible Functionalities and Barriers for Patients and Their General Practitioners

ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 1445-1455 | Published online: 08 Jul 2022

References

  • Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759–770. doi:10.1007/s00228-017-2225-3
  • Meier F, Maas R, Sonst A, et al. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs. Pharmacoepidemiol Drug Saf. 2015;24(2):176–186. doi:10.1002/pds.3663
  • Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58(4):285–291. doi:10.1007/s00228-002-0467-0
  • Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23. doi:10.1016/j.amjopharm.2011.02.004
  • Hsu KL, Fink JC, Ginsberg JS, et al. Self-reported medication adherence and adverse patient safety events in CKD. Am J Kidney Dis. 2015;66(4):621–629. doi:10.1053/j.ajkd.2015.03.026
  • Dormann H, Maas R, Eickhoff C, et al. [Standardized national medication plan: The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA]. Bundesgesundheitsbl. 2018;61(9):1093–1102. German. doi:10.1007/s00103-018-2789-9
  • De Vries ST, Denig P, Lasheras Ruiz C, et al. IMI Web-RADR Work Package 3b Consortium. Interest in a mobile app for two-way risk communication: a survey study among European healthcare professionals and patients. Drug Saf. 2018;41(7):697–712. doi:10.1007/s40264-018-0648-0
  • Pierce CE, De Vries ST, Bodin-Parssinen S, et al. Recommendations on the use of mobile applications for the collection and communication of pharmaceutical product safety information: lessons from IMI WEB-RADR. Drug Saf. 2019;42(4):477–489. doi:10.1007/s40264-019-00813-6
  • Montastruc F, Bagheri H, Lacroix I, et al. Adverse drug reaction reports received through the mobile app, VigiBIP®. A comparison with classical methods of reporting. Drug Saf. 2018;41(5):511–514. doi:10.1007/s40264-017-0630-2
  • Graber ML, Siegal D, Riah H, Johnston D, Kenyon K. Electronic health record–related events in medical malpractice claims. J Patient Saf. 2019;15(2):77–85. doi:10.1097/PTS.0000000000000240
  • Schneider EC, Ridgely MS, Meeker D, Hunter LE, Khodyakov D, Rudin RS. Promoting patient safety through effective health information technology risk management. Rand Health Q. 2014;4(3):7.
  • Ernsting C, Dombrowski SU, Oedekoven M, et al. Using smartphones and health apps to change and manage health behaviors: a population-based survey. J Med Internet Res. 2017;19(4):e101. doi:10.2196/jmir.6838
  • Demiris G, Krupinksi E, Washington K, et al. The role of human factors in telehealth. Telemed J E Health. 2010;16(4):446–453. doi:10.1089/tmj.2009.0114
  • Judge J, Field TS, DeFlorio M, et al. Prescribers’ responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc. 2006;13(4):385–390. doi:10.1197/jamia.M1945
  • Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inform. 2017;105:22–30. doi:10.1016/j.ijmedinf.2017.05.011
  • Webster RK, Weinman J, Rubin GJ. Medicine-related beliefs predict attribution of symptoms to a sham medicine: a prospective study. Br J Health Psychol. 2018;23(2):436–454. doi:10.1111/bjhp.12298
  • Carroll JK, Moorhead A, Bond R, LeBlanc WG, Petrella RJ, Fiscella K. Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res. 2017;19(4):e125. doi:10.2196/jmir.5604
  • Levine DM, Lipsitz SR, Linder JA. Trends in seniors’ use of digital health technology in the United States, 2011–2014. JAMA. 2016;316(5):538–540. doi:10.1001/jama.2016.9124
  • Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. doi:10.1001/jama.2017.7156
  • Kane-Gill SL, O’Connor MF, Rothschild JM, et al. Technologic distractions (part 1): summary of approaches to manage alert quantity with intent to reduce alert fatigue and suggestions for alert fatigue metrics. Crit Care Med. 2017;45(9):1481–1488. doi:10.1097/CCM.0000000000002580
  • De Vries ST, Wong L, Sutcliffe A, et al. Factors influencing the use of a mobile app for reporting adverse drug reactions and receiving safety information: a qualitative study. Drug Saf. 2017;40(5):443–455. doi:10.1007/s40264-016-0494-x
  • Sidorkiewicz S, Tran VT, Cousyn C, Perrodeau E, Ravaud P. Discordance between drug adherence as reported by patients and drug importance as assessed by physicians. Ann Fam Med. 2016;14(5):415–421. doi:10.1370/afm.1965
  • Ali EE, Leow JL, Chew L, Yap KY. Patients’ perception of app-based educational and behavioural interventions for enhancing oral anticancer medication adherence. J Canc Educ. 2018;33(6):1306–1313. doi:10.1007/s13187-017-1248-x
  • Santo K, Richtering SS, Chalmers J, Thiagalingam A, Chow CK, Redfern J. Mobile phone apps to improve medication adherence: a systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth. 2016;4(4):e132. doi:10.2196/mHealth.6742